Global Health Impact Fund

Global Health Impact Network, Inc. is a digital health community that facilitates collaboration among healthcare professionals to advance digital health innovation. Established in 2019 and located in Walnut Creek, California, the company provides a communication platform where members can learn about startup methodologies, digital transformation, and innovation strategies. It enables healthcare professionals to stay informed about emerging technologies, including 5G, the Internet of Health Things, artificial intelligence, cloud computing, telehealth, genomics, and data growth. By fostering a network of like-minded individuals across various professions and specialties, Global Health Impact Network empowers healthcare professionals to actively engage in shaping the future of digital healthcare.

Rachna Goel

General Partner and COO

Gary Goldman

CEO and Founder

Sheetal Nariani

CFO and General Partner

Robert E. Sweeney

Co-Founder and Principal

3 past transactions

Raydiant Oximetry

Series A in 2024
Raydiant Oximetry, Inc. is a medical device company founded in 2015 and headquartered in Mountain View, California. The company focuses on improving childbirth outcomes for mothers and infants by developing a low-cost, non-invasive device that monitors fetal oxygen levels during labor. This innovative technology aims to provide real-time insights into fetal oxygenation, which can help clinicians make informed decisions and reduce the risks associated with childbirth, such as birth injuries and unnecessary cesarean sections. By enhancing patient care and potentially lowering healthcare costs, Raydiant Oximetry's device addresses critical needs in maternal and fetal health.

Elucid

Series A in 2021
Elucid, located in the Boston biotech and medtech hub, specializes in enhancing the accuracy and cost-effectiveness of cardiovascular diagnostic imaging through machine learning. Its flagship product, ElucidVivo, is the first FDA-cleared software that evaluates plaque vulnerability from a single computed tomography angiography (CTA) scan, aiding in the assessment of heart attack and stroke risk as well as treatment selection. The company also collaborates with pharmaceutical firms, healthcare providers, and research organizations to offer quantitative image analysis services. By applying artificial intelligence to vascular diagnostics, Elucid aims to improve patient outcomes while providing a non-invasive and economically efficient means of capturing critical health information, thereby supporting cardiovascular pathologists in delivering comprehensive clinical insights.

Plethy

Seed Round in 2019
Plethy is an InsurTech and HealthTech company focused on enhancing patient outcomes and financial returns for self-insured enterprises, insurance carriers, and health systems. The company has developed a care management platform that helps patients manage their musculoskeletal care from the comfort of their homes or while on the go. This platform integrates a wearable sensor with a software application, allowing patients to adhere to their treatment plans effectively. By leveraging predictive analytics, Plethy provides valuable insights into patient recovery and claims closure, enabling healthcare providers to improve remote monitoring and achieve a balance between quality, access, and cost in patient care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.